Location: Dallas, TX
CIK: 0001617201 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $410M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLPG | GALAPAGOS NV | 1,773,649 | $49.64M | 12.1% | $33.19 | — | SPON ADR | 36315X101 |
| UNH | UNITEDHEALTH GROUP INC | 110,000 | $34.32M | 8.4% | $374.94 | 0.0% | COM | 91324P102 |
| MGTX | MEIRAGTX HLDGS PLC | 4,587,423 | $29.91M | 7.3% | $6.93 | -14.9% | COM | G59665102 |
| ADCT | ADC THERAPEUTICS SA | 10,467,771 | $28.05M | 6.8% | $3.11 | -32.4% | SHS | H0036K147 |
| BBIO | BRIDGEBIO PHARMA INC | 472,687 | $20.41M | 5.0% | $30.67 | +18.6% | COM | 10806X102 |
| ROIV | ROIVANT SCIENCES LTD | 1,808,539 | $20.38M | 5.0% | $10.80 | +0.4% | SHS | G76279101 |
| FOLD | AMICUS THERAPEUTICS INC | 3,480,044 | $19.94M | 4.9% | $7.87 | -17.9% | COM | 03152W109 |
| JANX | JANUX THERAPEUTICS INC | 853,904 | $19.73M | 4.8% | $39.13 | -32.7% | COM | 47103J105 |
| KURA | KURA ONCOLOGY INC | 3,181,184 | $18.36M | 4.5% | $9.51 | -35.6% | COM | 50127T109 |
| ZYME | ZYMEWORKS INC | 1,309,904 | $16.44M | 4.0% | $10.69 | +11.5% | COM | 98985Y108 |
| ICLR | ICON PLC | 98,558 | $14.34M | 3.5% | $197.74 | -28.3% | SHS | G4705A100 |
| ARGX | ARGENX SE | 22,000 | $12.13M | 3.0% | $576.53 | — | SPONSORED ADR | 04016X101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 200,000 | $10.18M | 2.5% | $29.75 | +49.6% | COM | 604749101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,079,673 | $10.11M | 2.5% | $16.38 | -32.8% | COM | 87164F105 |
| TECX | TECTONIC THERAPEUTIC INC | 442,056 | $8.784M | 2.1% | $31.39 | -35.4% | COM | 878972108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 298,123 | $8.574M | 2.1% | $30.88 | 0.0% | COM | 22663K107 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,517,113 | $7.984M | 1.9% | $1.23 | +31.4% | COM | 23284F105 |
| IMVT | IMMUNOVANT INC | 479,400 | $7.67M | 1.9% | $27.05 | -44.1% | COM | 45258J102 |
| BHVN | BIOHAVEN LTD | 539,071 | $7.606M | 1.9% | $21.06 | -15.4% | COM | G1110E107 |
| CON | CONCENTRA GROUP HOLDINGS PAR | 312,105 | $6.42M | 1.6% | $21.20 | 0.0% | COMMON STOCK | 20603L102 |
| LIVN | LIVANOVA PLC | 140,000 | $6.303M | 1.5% | $46.88 | -12.0% | SHS | G5509L101 |
| DXCM | DEXCOM INC | 70,000 | $6.11M | 1.5% | $78.38 | 0.0% | COM | 252131107 |
| CDNA | CAREDX INC | 302,808 | $5.917M | 1.4% | $20.20 | -12.1% | COM | 14167L103 |
| SEM | SELECT MED HLDGS CORP | 353,820 | $5.371M | 1.3% | $15.42 | 0.0% | COM | 81619Q105 |
| STTK | SHATTUCK LABS INC | 6,638,935 | $5.257M | 1.3% | $5.19 | -81.3% | COM | 82024L103 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 211,816 | $4.806M | 1.2% | $45.33 | -47.7% | COM | 00404A109 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 579,893 | $4.001M | 1.0% | $20.33 | -64.3% | COM NEW | 21833P301 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,580,588 | $3.872M | 0.9% | $13.68 | -63.0% | COM | 77313F106 |
| SGHT | SIGHT SCIENCES INC | 871,687 | $3.6M | 0.9% | $5.64 | -40.8% | COM | 82657M105 |
| AXGN | AXOGEN INC | 282,809 | $3.068M | 0.7% | $13.10 | 0.0% | COM | 05463X106 |
| LNTH | LANTHEUS HLDGS INC | 34,576 | $2.83M | 0.7% | $87.82 | 0.0% | COM | 516544103 |
| — | MURAL ONCOLOGY PUB LTD CO | 900,000 | $2.223M | 0.5% | $3.70 | — | ORD SHS | G63365103 |
| PRTA | PROTHENA CORP PLC | 267,800 | $1.626M | 0.4% | $26.88 | -72.1% | SHS | G72800108 |
| KIDS | ORTHOPEDIATRICS CORP | 73,647 | $1.582M | 0.4% | $21.62 | 0.0% | COM | 68752L100 |
| PLRX | PLIANT THERAPEUTICS INC | 837,400 | $971K | 0.2% | $3.27 | -56.8% | COM | 729139105 |
| RNTX | REIN THERAPEUTICS INC | 427,919 | $599K | 0.1% | $3.55 | -49.3% | COM NEW | 00887A204 |
| OKUR | ONKURE THERAPEUTICS INC | 159,692 | $382K | 0.1% | $8.87 | -70.5% | COM CL A | 68277Q105 |
| ERAS | ERASCA INC | 240,295 | $305K | 0.1% | $2.11 | -36.7% | COM | 29479A108 |
| PEPG | PEPGEN INC | 243,980 | $271K | 0.1% | $1.41 | 0.0% | COM | 713317105 |